CAS No.:317-52-2
Name: Hexafluorenium bromide
Details Introduction
TOXICITY DATA with REFERENCE：
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| human | TDLo | intravenous | 400ug/kg (0.4mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING | "Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents," National Research Council, 3 vols., Washington, DC, National Academy Press, 1982-85Vol. 1, Pg. E1, 1982. |
| mouse | LD50 | intravenous | 1760ug/kg (1.76mg/kg) | Biochemical Pharmacology. Vol. 2, Pg. 233, 1959. | |
| mouse | LD50 | oral | 280mg/kg (280mg/kg) | Proceedings of the Society for Experimental Biology and Medicine. Vol. 85, Pg. 603, 1954. | |
| mouse | LD50 | subcutaneous | 240mg/kg (240mg/kg) | Proceedings of the Society for Experimental Biology and Medicine. Vol. 85, Pg. 603, 1954. | |
| rabbit | LD50 | intravenous | 80ug/kg (0.08mg/kg) | Pharmacology and Toxicology. English translation of FATOAO. Vol. 22, Pg. 200, 1959. | |
| rat | LD50 | intraperitoneal | 20mg/kg (20mg/kg) | Compilation of LD50 Values of New Drugs. |
Consensus Reports：
SAFETY PROFILE：
A poison by intraperitoneal, subcutaneous, and intravenous routes. Human systemic effects by intravenous route: nausea or vomiting, cholinesterase changes. When heated to decomposition it emits very toxic fumes of NH3, NOx, and Br−. See also BROMIDES.
Standards and Recommendations：
Analytical Methods：
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione